Iron provision via transferrin has a significant contribution to the behavior of both non-leukemic CD34+ cells and AML blasts ex vivo, with the former being more resistant to cell death than the latter when enough Tf is provided (Figure 2). This evidence concerns the gene TF and acute myeloid leukemia.